Found: 6
Select item for more details and to access through your institution.
Psychiatrists' perceptions of the clinical importance, assessment and management of patient functioning in schizophrenia in Europe, the Middle East and Africa.
- Published in:
- Annals of General Psychiatry, 2013, v. 12, n. 1, p. 8, doi. 10.1186/1744-859X-12-8
- By:
- Publication type:
- Article
Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study.
- Published in:
- Psychopharmacology, 2017, v. 234, n. 1, p. 3, doi. 10.1007/s00213-016-4445-0
- By:
- Publication type:
- Article
Janssen-Neues aus Klinik und Forschung.
- Published in:
- Neuropsychiatrie, 2012, p. 12
- By:
- Publication type:
- Article
Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 1365, doi. 10.2147/NDT.S197225
- By:
- Publication type:
- Article
Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 587, doi. 10.2147/NDT.S189668
- By:
- Publication type:
- Article
Once-monthly paliperidone palmitate in early stage schizophrenia - a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 2261, doi. 10.2147/NDT.S142634
- By:
- Publication type:
- Article